DNA X, Inc. (SONM) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$5.41M | -74.4% |
| 2024 | -$3.10M | -704.3% |
| 2023 | $513.0K | +103.6% |
| 2022 | -$14.29M | +62.4% |
| 2021 | -$38.00M | -29.9% |
| 2020 | -$29.26M | -30.7% |
| 2019 | -$22.38M | -514.9% |
| 2018 | $5.39M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$5.41M | -74.4% |
| 2024 | -$3.10M | -704.3% |
| 2023 | $513.0K | +103.6% |
| 2022 | -$14.29M | +62.4% |
| 2021 | -$38.00M | -29.9% |
| 2020 | -$29.26M | -30.7% |
| 2019 | -$22.38M | -514.9% |
| 2018 | $5.39M | — |